{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T04:27:40Z","timestamp":1791779260055,"version":"4.3.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatologie"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00105-025-05537-6","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T09:54:00Z","timestamp":1753696440000},"page":"470-479","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["H\u00e4ufige Haut- und Weichgewebeinfektionen\u00a0\u2013 aktuelle Empfehlungen","Common skin and soft tissue infections\u2014current recommendations"],"prefix":"10.1007","volume":"76","author":[{"given":"Cord","family":"Sunderk\u00f6tter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Schieffers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Ehrchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"key":"5537_CR1","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S1473-3099(20)30523-5","volume":"21","author":"A Babiker","year":"2021","unstructured":"Babiker\u00a0A, Li\u00a0X, Lai\u00a0YL et\u00a0al (2021) Effectiveness of adjunctive clindamycin in beta-lactam antibiotic-treated patients with invasive beta-haemolytic streptococcal infections in US hospitals: a\u00a0retrospective multicentre cohort study. Lancet Infect Dis 21:697\u2013710","journal-title":"Lancet Infect Dis"},{"key":"5537_CR2","volume-title":"Mikrobiologisch-infektiologische Qualit\u00e4tsstandards (MiQ)","author":"K Becker","year":"2013","unstructured":"Becker\u00a0K, Podbielski\u00a0A, Sunderk\u00f6tter\u00a0C et\u00a0al (2013) Infektionen der Haut und der subkutanen Weichteile Teil\u00a0I und II. In: Podbielski\u00a0A, Herrmann\u00a0M, Kniehl\u00a0E, Mauch H\u00a0HR (Hrsg) Mikrobiologisch-infektiologische Qualit\u00e4tsstandards (MiQ). Elsevier, Urban und Fischer, Munich"},{"key":"5537_CR3","volume-title":"Mikrobiologisch-infektiologische Qualit\u00e4tsstandards (MiQ 6a)","author":"K Becker","year":"2013","unstructured":"Becker\u00a0K, Podbielski\u00a0A, Sunderk\u00f6tter\u00a0C et\u00a0al (2013) Infektionen der Haut und der subkutanen Weichteile Teil\u00a0I. In: Podbielski\u00a0A, Herrmann\u00a0A, Kniehl\u00a0E, Mauch\u00a0H, R\u00fcssmann\u00a0H (Hrsg) Mikrobiologisch-infektiologische Qualit\u00e4tsstandards (MiQ 6a). Elsevier Urban and Fischer M\u00fcnchen,"},{"key":"5537_CR4","doi-asserted-by":"publisher","first-page":"ofz270","DOI":"10.1093\/ofid\/ofz270","volume":"6","author":"M Beganovic","year":"2019","unstructured":"Beganovic\u00a0M, Cusumano\u00a0JA, Lopes\u00a0V et\u00a0al (2019) Comparative Effectiveness of Exclusive Exposure to Nafcillin or Oxacillin, Cefazolin, Piperacillin\/Tazobactam, and Fluoroquinolones Among a\u00a0National Cohort of Veterans With Methicillin-Susceptible Staphylococcus aureus Bloodstream Infection. Open Forum Infect Dis 6:ofz270","journal-title":"Open Forum Infect Dis"},{"key":"5537_CR5","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1136\/bmj.325.7369.864","volume":"325","author":"P Bernard","year":"2002","unstructured":"Bernard\u00a0P, Chosidow\u00a0O, Vaillant\u00a0L (2002) Oral pristinamycin versus standard penicillin regimen to treat erysipelas in adults: randomised, non-inferiority, open trial. BMJ 325:864","journal-title":"BMJ"},{"key":"5537_CR6","doi-asserted-by":"crossref","unstructured":"Chakroun M, Romdhane BF, Battikh R et\u00a0al (1994) Benzathine penicillin prophylaxis in recurrent erysipelas Med Mal Infect. 24:894\u2013897","DOI":"10.1016\/S0399-077X(05)80579-7"},{"key":"5537_CR7","first-page":"CD009758","volume":"6","author":"A Dalal","year":"2017","unstructured":"Dalal\u00a0A, Eskin-Schwartz\u00a0M, Mimouni\u00a0D et\u00a0al (2017) Interventions for the prevention of recurrent erysipelas and cellulitis. Cochrane Database Syst Rev 6:CD9758","journal-title":"Cochrane Database Syst Rev"},{"key":"5537_CR8","doi-asserted-by":"publisher","first-page":"607","DOI":"10.2217\/pgs.10.24","volume":"11","author":"AK Daly","year":"2010","unstructured":"Daly\u00a0AK (2010) Drug-induced liver injury: past, present and future. Pharmacogenomics 11:607\u2013611","journal-title":"Pharmacogenomics"},{"key":"5537_CR9","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1056\/NEJMoa1607033","volume":"376","author":"RS Daum","year":"2017","unstructured":"Daum\u00a0RS, Miller\u00a0LG, Immergluck\u00a0L et\u00a0al (2017) A Placebo-Controlled Trial of Antibiotics for Smaller Skin Abscesses. N\u00a0Engl J Med 376:2545\u20132555","journal-title":"N Engl J Med"},{"key":"5537_CR10","first-page":"1417","volume":"18","author":"C Drerup","year":"2020","unstructured":"Drerup\u00a0C, Eveslage\u00a0M, Sunderkoetter\u00a0C et\u00a0al (2020) Diagnostic value of laboratory parameters for the discrimination between erysipelas and limited cellulitis. J\u00a0Dtsch Dermatol Ges 18:1417\u20131424","journal-title":"J Dtsch Dermatol Ges"},{"key":"5537_CR11","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.annemergmed.2009.03.014","volume":"55","author":"M Duong","year":"2010","unstructured":"Duong\u00a0M, Markwell\u00a0S, Peter\u00a0J et\u00a0al (2010) Randomized, controlled trial of antibiotics in the management of community-acquired skin abscesses in the pediatric patient. Ann Emerg Med 55:401\u2013407","journal-title":"Ann Emerg Med"},{"key":"5537_CR12","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1136\/bmj.318.7198.1591","volume":"318","author":"A Dupuy","year":"1999","unstructured":"Dupuy\u00a0A, Benchikhi\u00a0H, Roujeau\u00a0JC et\u00a0al (1999) Risk factors for erysipelas of the leg (cellulitis): case-control study. BMJ 318:1591\u20131594","journal-title":"BMJ"},{"key":"5537_CR13","doi-asserted-by":"crossref","unstructured":"Eljaaly K, Alshehri S, Erstad BL (2018) Systematic Review and Meta-analysis of the Safety of Antistaphylococcal Penicillins Compared to Cefazolin. Antimicrob Agents Chemother 62:","DOI":"10.1128\/AAC.01816-17"},{"key":"5537_CR14","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1017\/cem.2014.52","volume":"17","author":"J Fahimi","year":"2015","unstructured":"Fahimi\u00a0J, Singh\u00a0A, Frazee\u00a0BW (2015) The role of adjunctive antibiotics in the treatment of skin and soft tissue abscesses: a\u00a0systematic review and meta-analysis. CJEM 17:420\u2013432","journal-title":"CJEM"},{"key":"5537_CR15","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1016\/S0140-6736(14)62001-8","volume":"385","author":"M Hentzien","year":"2015","unstructured":"Hentzien\u00a0M, Lambert\u00a0D, Limelette\u00a0A et\u00a0al (2015) Macroscopic amoxicillin crystalluria. Lancet 385:2296","journal-title":"Lancet"},{"key":"5537_CR16","doi-asserted-by":"crossref","unstructured":"Heuser E, Becker K, Idelevich EA (2022) Bactericidal Activity of Sodium Bituminosulfonate against Staphylococcus aureus. Antibiot (basel) 11:","DOI":"10.3390\/antibiotics11070896"},{"key":"5537_CR17","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1089\/mdr.2019.0390","volume":"26","author":"EA Idelevich","year":"2020","unstructured":"Idelevich\u00a0EA, Becker\u00a0K (2020) In Vitro Activity of Sodium Bituminosulfonate: Susceptibility Data for the Revival of an Old Antimicrobial. Microb Drug Resist 26:1405\u20131409","journal-title":"Microb Drug Resist"},{"key":"5537_CR18","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S0924-8579(03)00154-7","volume":"22","author":"ME Jones","year":"2003","unstructured":"Jones\u00a0ME, Karlowsky\u00a0JA, Draghi\u00a0DC et\u00a0al (2003) Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a\u00a0guide to appropriate antimicrobial therapy. Int J Antimicrob Agents 22:406\u2013419","journal-title":"Int J Antimicrob Agents"},{"key":"5537_CR19","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3109\/00365548609021656","volume":"18","author":"C Jorup-Ronstrom","year":"1986","unstructured":"Jorup-Ronstrom\u00a0C (1986) Epidemiological, bacteriological and complicating features of erysipelas. Scand J Infect Dis 18:519\u2013524","journal-title":"Scand J Infect Dis"},{"key":"5537_CR20","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/BF01645222","volume":"12","author":"C Jorup-Ronstrom","year":"1984","unstructured":"Jorup-Ronstrom\u00a0C, Britton\u00a0S, Gavlevik\u00a0A et\u00a0al (1984) The course, costs and complications of oral versus intravenous penicillin therapy of erysipelas. Infection 12:390\u2013394","journal-title":"Infection"},{"key":"5537_CR21","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s15010-019-01382-7","volume":"48","author":"S Karakonstantis","year":"2020","unstructured":"Karakonstantis\u00a0S (2020) Is coverage of S.\u00a0aureus necessary in cellulitis\/erysipelas? A\u00a0literature review. Infection 48:183\u2013191","journal-title":"Infection"},{"key":"5537_CR22","doi-asserted-by":"crossref","unstructured":"Kilburn SA, Featherstone P, Higgins B et\u00a0al (2010) Interventions for cellulitis and erysipelas. Cochrane Database Syst Rev: CD4299","DOI":"10.1002\/14651858.CD004299.pub2"},{"key":"5537_CR23","unstructured":"Kujath P, Eckmann C, Graninger W et\u00a0al. (2010) Haut- und Weichgewebe\u2011, Knochen- und Gelenkinfektionen. In Bodmann K.F, Grabein B, Expertenkommission der Paul-Ehrlich-Gesellschaft f\u00fcr Chemotherapie e.\u202fV. Empfehlungen zur kalkulierten parenteralen Initialtherapie Bakterieller Erkrankungen bei Erwachsenen \u2013 Update 2010 2010 58\u201364. In: Bodmann K, Grabein B (eds) Expertenkommission der Paul-Ehrlich-Gesellschaft f\u00fcr Chemotherapie e.\u202fV. Empfehlungen zur kalkulierten parenteralen Initialtherapie Bakterieller Erkrankungen bei Erwachsenen \u2013 Update 2010 PEG"},{"key":"5537_CR24","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/apm.13304","volume":"131","author":"C Kursawe Larsen","year":"2023","unstructured":"Kursawe Larsen\u00a0C, Kjaersgaard Andersen\u00a0R, Saunte\u00a0DML et\u00a0al (2023) Primary skin abscess microbiota a\u00a0systematic review. Apmis 131:183\u2013188","journal-title":"Apmis"},{"key":"5537_CR25","first-page":"46","volume":"15","author":"CW Linder","year":"1993","unstructured":"Linder\u00a0CW, Nelson\u00a0K, Paryani\u00a0S et\u00a0al (1993) Comparative evaluation of cefadroxil and cephalexin in children and adolescents with pyodermas. Cefadroxil Once Dly Pyoderma Study Group Clin Ther 15:46\u201356","journal-title":"Cefadroxil Once Dly Pyoderma Study Group Clin Ther"},{"key":"5537_CR26","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1086\/520743","volume":"28","author":"BA Lipsky","year":"2007","unstructured":"Lipsky\u00a0BA, Weigelt\u00a0JA, Gupta\u00a0V et\u00a0al (2007) Skin, soft tissue, bone, and joint infections in hospitalized patients: epidemiology and microbiological, clinical, and economic outcomes. Infect Control Hosp Epidemiol 28:1290\u20131298","journal-title":"Infect Control Hosp Epidemiol"},{"key":"5537_CR27","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/jac\/dkae419","volume":"80","author":"E Mcguire","year":"2025","unstructured":"Mcguire\u00a0E, Ready\u00a0D, Ellaby\u00a0N et\u00a0al (2025) A case of penicillin-resistant group\u00a0B Streptococcus isolated from a\u00a0patient in the UK. J\u00a0Antimicrob Chemother 80:399\u2013404","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 4","key":"5537_CR28","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.3949\/ccjm.74.Suppl_4.S21","volume":"74","author":"JI Merlino","year":"2007","unstructured":"Merlino\u00a0JI, Malangoni\u00a0MA (2007) Complicated skin and soft-tissue infections: diagnostic approach and empiric treatment options. Cleve Clin J Med 74(Suppl 4):S21\u201328","journal-title":"Cleve Clin J Med"},{"key":"5537_CR29","first-page":"405","volume":"46","author":"LM Miller","year":"1989","unstructured":"Miller\u00a0LM, Mooney\u00a0CJ, Hansbrough\u00a0JF (1989) Comparative evaluation of cefaclor versus cefadroxil in the treatment of skin and skin structure infections. Curr Ther Res Exp 46:405\u2013410","journal-title":"Curr Ther Res Exp"},{"key":"5537_CR30","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s00423-020-01941-9","volume":"406","author":"AYY Mohamedahmed","year":"2021","unstructured":"Mohamedahmed\u00a0AYY, Zaman\u00a0S, Stonelake\u00a0S et\u00a0al (2021) Incision and drainage of cutaneous abscess with or without cavity packing: a\u00a0systematic review, meta-analysis, and trial sequential analysis of randomised controlled trials. Langenbecks Arch Surg 406:981\u2013991","journal-title":"Langenbecks Arch Surg"},{"key":"5537_CR31","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1093\/jac\/dkad263","volume":"78","author":"HT Mok","year":"2023","unstructured":"Mok\u00a0HT, Teng\u00a0CB, Bergin\u00a0S et\u00a0al (2023) Treatment outcomes with benzylpenicillin and non-benzylpenicillin antibiotics, and the performance of the penicillin zone-edge test versus molecular detection of blaZ in penicillin-susceptible Staphylococcus aureus (PSSA) bacteraemia. J\u00a0Antimicrob Chemother 78:2515\u20132523","journal-title":"J Antimicrob Chemother"},{"key":"5537_CR32","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1001\/jama.2017.5653","volume":"317","author":"GJ Moran","year":"2017","unstructured":"Moran\u00a0GJ, Krishnadasan\u00a0A, Mower\u00a0WR et\u00a0al (2017) Effect of Cephalexin Plus Trimethoprim-Sulfamethoxazole vs Cephalexin Alone on Clinical Cure of Uncomplicated Cellulitis: A\u00a0Randomized Clinical Trial. JAMA 317:2088\u20132096","journal-title":"JAMA"},{"key":"5537_CR33","doi-asserted-by":"crossref","unstructured":"Muteeb G, Rehman MT, Shahwan M et\u00a0al (2023) Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A\u00a0Narrative Review. Pharm (basel) 16:","DOI":"10.20944\/preprints202306.1921.v1"},{"key":"5537_CR34","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/j.1553-2712.2009.00409.x","volume":"16","author":"GF O\u2019malley","year":"2009","unstructured":"O\u2019malley\u00a0GF, Dominici\u00a0P, Giraldo\u00a0P et\u00a0al (2009) Routine packing of simple cutaneous abscesses is painful and probably unnecessary. Acad Emerg Med 16:470\u2013473","journal-title":"Acad Emerg Med"},{"key":"5537_CR35","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jinf.2014.02.011","volume":"69","author":"CC Oh","year":"2014","unstructured":"Oh\u00a0CC, Ko\u00a0HC, Lee\u00a0HY et\u00a0al (2014) Antibiotic prophylaxis for preventing recurrent cellulitis: a\u00a0systematic review and meta-analysis. J\u00a0Infect 69:26\u201334","journal-title":"J Infect"},{"key":"5537_CR36","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/acem.12371","volume":"21","author":"D Peterson","year":"2014","unstructured":"Peterson\u00a0D, Mcleod\u00a0S, Woolfrey\u00a0K et\u00a0al (2014) Predictors of failure of empiric outpatient antibiotic therapy in emergency department patients with uncomplicated cellulitis. Acad Emerg Med 21:526\u2013531","journal-title":"Acad Emerg Med"},{"key":"5537_CR37","doi-asserted-by":"publisher","first-page":"4044","DOI":"10.1128\/AAC.00377-07","volume":"51","author":"PM Rajendran","year":"2007","unstructured":"Rajendran\u00a0PM, Young\u00a0D, Maurer\u00a0T et\u00a0al (2007) Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a\u00a0population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection. Antimicrob Agents Chemother 51:4044\u20134048","journal-title":"Antimicrob Agents Chemother"},{"key":"5537_CR38","unstructured":"Schieffers H, Sunderk\u00f6tter C (2025) Fr\u00fche Allgemeinsymptome und Ansprechen auf Penicillin G bei Erysipel \u2013 monozentrische retrospektive exploratorische Studie J Dtsch Dermatol Ges"},{"key":"5537_CR39","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1002\/phar.2124","volume":"38","author":"MD Shah","year":"2018","unstructured":"Shah\u00a0MD, Wardlow\u00a0LC, Stevenson\u00a0KB et\u00a0al (2018) Clinical Outcomes with Penicillin Versus Alternative beta-Lactams in the Treatment of Penicillin-Susceptible Staphylococcus aureus Bacteremia. Pharmacotherapy 38:769\u2013775","journal-title":"Pharmacotherapy"},{"key":"5537_CR40","unstructured":"Sunderk\u00f6tter C, Becker C, Eckmann W et\u00a0al. (2025) S2k-Leitlinie Haut- und Weichgewebeinfektionen. Auszug aus \u201eKalkulierte parenterale Initialtherapie bakterieller Erkrankungen bei Erwachsenen \u2013 Update 2025\u201c. in Vorbereitung"},{"key":"5537_CR41","first-page":"501","volume":"13","author":"C Sunderk\u00f6tter","year":"2015","unstructured":"Sunderk\u00f6tter\u00a0C, Becker\u00a0K (2015) Frequent bacterial skin and soft tissue infections: diagnostic signs and treatment. J\u00a0Dtsch Dermatol Ges 13:501\u2013524 (quiz 525\u2013506)","journal-title":"J Dtsch Dermatol Ges"},{"key":"5537_CR42","first-page":"345","volume":"17","author":"C Sunderk\u00f6tter","year":"2019","unstructured":"Sunderk\u00f6tter\u00a0C, Becker\u00a0K, Eckmann\u00a0C et\u00a0al (2019) S2k-Leitlinie Haut- und WeichgewebeinfektionenAuszug aus \u201eKalkulierte parenterale Initialtherapie bakterieller Erkrankungen bei Erwachsenen \u2013 Update 2018\u201c. J\u00a0Dtsch Dermatol Ges 17:345\u2013371","journal-title":"J Dtsch Dermatol Ges"},{"key":"5537_CR43","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1007\/s00105-023-05229-z","volume":"74","author":"C Sunderk\u00f6tter","year":"2023","unstructured":"Sunderk\u00f6tter\u00a0C, Michl\u00a0C (2023) Practicability of the German guidelines on skin and soft tissue infections. Dermatologie (heidelb) 74:858\u2013863","journal-title":"Dermatologie (Heidelb)"},{"key":"5537_CR44","first-page":"2245","volume":"370","author":"DA Talan","year":"2014","unstructured":"Talan\u00a0DA, Singer\u00a0AJ (2014) Management of skin abscesses. N\u00a0Engl J Med 370:2245\u20132246","journal-title":"N Engl J Med"},{"key":"5537_CR45","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1056\/NEJMoa1206300","volume":"368","author":"KS Thomas","year":"2013","unstructured":"Thomas\u00a0KS, Crook\u00a0AM, Nunn\u00a0AJ et\u00a0al (2013) Penicillin to prevent recurrent leg cellulitis. N\u00a0Engl J Med 368:1695\u20131703","journal-title":"N Engl J Med"},{"key":"5537_CR46","doi-asserted-by":"publisher","first-page":"e020991","DOI":"10.1136\/bmjopen-2017-020991","volume":"8","author":"W Wang","year":"2018","unstructured":"Wang\u00a0W, Chen\u00a0W, Liu\u00a0Y et\u00a0al (2018) Antibiotics for uncomplicated skin abscesses: systematic review and network meta-analysis. Bmj Open 8:e20991","journal-title":"Bmj Open"},{"key":"5537_CR47","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1089\/lrb.2022.0029","volume":"21","author":"E Webb","year":"2023","unstructured":"Webb\u00a0E, Bissett\u00a0B, Neeman\u00a0T et\u00a0al (2023) Compression Therapy Is Cost-Saving in the Prevention of Lower Limb Recurrent Cellulitis in Patients with Chronic Edema. Lymphat Res Biol 21:160\u2013168","journal-title":"Lymphat Res Biol"},{"key":"5537_CR48","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1056\/NEJMoa1917197","volume":"383","author":"E Webb","year":"2020","unstructured":"Webb\u00a0E, Neeman\u00a0T, Bowden\u00a0FJ et\u00a0al (2020) Compression Therapy to Prevent Recurrent Cellulitis of the Leg. N\u00a0Engl J Med 383:630\u2013639","journal-title":"N Engl J Med"},{"key":"5537_CR49","doi-asserted-by":"crossref","unstructured":"Williams OM, Brindle R (2020) Antibiotic route and duration of therapy for cellulitis: data extracted from a\u00a0multi-center clinical trial. Int J Antimicrob Agents 56: (106076)","DOI":"10.1016\/j.ijantimicag.2020.106076"},{"key":"5537_CR50","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s15010-022-01842-7","volume":"50","author":"K Yadav","year":"2022","unstructured":"Yadav\u00a0K, Krzyzaniak\u00a0N, Alexander\u00a0C et\u00a0al (2022) The impact of antibiotics on clinical response over time in uncomplicated cellulitis: a\u00a0systematic review and meta-analysis. Infection 50:859\u2013871","journal-title":"Infection"},{"key":"5537_CR51","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s15010-019-01347-w","volume":"48","author":"K Yadav","year":"2020","unstructured":"Yadav\u00a0K, Nath\u00a0A, Suh\u00a0KN et\u00a0al (2020) Treatment failure definitions for non-purulent skin and soft tissue infections: a\u00a0systematic review. Infection 48:75\u201383","journal-title":"Infection"},{"key":"5537_CR52","first-page":"1041","volume":"20","author":"M Zidane","year":"2022","unstructured":"Zidane\u00a0M, Jungkunz\u00a0HW, Kahle\u00a0B et\u00a0al (2022) S1 guideline: differential diagnosis of acute and chronic redness of the lower legs. J\u00a0Dtsch Dermatol Ges 20:1041\u20131047","journal-title":"J Dtsch Dermatol Ges"},{"key":"5537_CR53","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.jinf.2019.10.008","volume":"79","author":"P Zimmermann","year":"2019","unstructured":"Zimmermann\u00a0P, Curtis\u00a0N (2019) The effect of antibiotics on the composition of the intestinal microbiota\u2014a\u00a0systematic review. J\u00a0Infect 79:471\u2013489","journal-title":"J Infect"}],"container-title":["Die Dermatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-025-05537-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-025-05537-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-025-05537-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T08:45:01Z","timestamp":1757321101000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-025-05537-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":53,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["5537"],"URL":"https:\/\/doi.org\/10.1007\/s00105-025-05537-6","relation":{},"ISSN":["2731-7005","2731-7013"],"issn-type":[{"value":"2731-7005","type":"print"},{"value":"2731-7013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,28]]},"assertion":[{"value":"13 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"C.\u00a0Sunderk\u00f6tter ist als Referent f\u00fcr die Firmen InfectoPharm, Pfizer, Almirall, GlaxoSmithKline (GSK), Janssen, Biotest, Boehringer Ingelheim t\u00e4tig. K.\u00a0Becker ist als Referent f\u00fcr Advanz, Pfizer und Shionogi sowie als Berater f\u00fcr das Deutsche Zentrum f\u00fcr Infektionsforschung e.\u202fV. (DZIF) t\u00e4tig. J. Ehrchen ist als Referent t\u00e4tig f\u00fcr Celltrion, Biogen, Infectopharm, ABBVIE, AstraZeneca, Boehringer-Ingelheim, BMS, GSK, Almirall, Lilly, SOBI und in Advisory Boards f\u00fcr Johnson & Johnson, SOBI une Boehringer-Ingelheim. H.\u00a0Schieffers gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}